Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Learn timing strategies for harvesting gains in retirement index funds, including tax-aware harvest windows and portfolio rebalancing tips.
21,836 articlesA cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Wintermute is stepping into the prediction-market arena by supplying liquidity on Kalshi and Polymarket, aiming to li...
As lawmakers push a sweeping crypto regulation bill, the former president's outspoken support for digital assets is c...
The Trump administration faces a court-backed pause on universal tariff refunds, even as more than $20 billion has al...
Ripple expands its RLUSD stablecoin into Turkey, backing a push for institutional, regulation-friendly digital dollar...
A weekend meteor over New England, described as elephant-sized by NASA, created loud booms and sparked a fresh look a...
As earnings season arrives, sprinklr (cxm) 2026 earnings take center stage for investors watching the CXM software sp...
The World Cup sticker craze is rising in the United States as fans stock up on Panini packs. This year’s North Americ...
In the AI boom, everyone chase chips and models. But the most important company you've probably never heard of sits b...
A Ligand Pharmaceuticals insider recently sold 5,000 shares, triggering discussions about what insider moves signal f...
Trump argues against rate hikes amid a stubborn inflation backdrop, while Kevin Warsh appears set to influence a hawk...
A fast-spreading pest that could devastate cattle operations has surfaced in Texas and now New Mexico, posing fresh f...